The missing link: chemokine receptors and tissue matrix breakdown in COPD

Trends in Pharmacological Sciences

Volumn 27, Issue 11, 2006, Pages 555-557

  Smit, Joost J ^a   Lukacs, Nicholas W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CXCR2; PEPTIDE; PROTEINASE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXTRACELLULAR MATRIX; HUMAN; LUNG ALVEOLUS MACROPHAGE; MEDIATOR RELEASE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SHORT SURVEY; SMOKING CESSATION; T LYMPHOCYTE;

ANIMALS; CHEMOTAXIS; EXTRACELLULAR MATRIX; HUMANS; LUNG; MACROPHAGES, ALVEOLAR; NEUTROPHILS; PEPTIDE FRAGMENTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-8B;

EID: 33749992653     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2006.09.003     Document Type: Short Survey

References (13)

1. Barnes P.J. Mediators of chronic obstructive pulmonary disease. Pharmacol. Rev. 56 (2004) 515-548
2. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc. Am. Thorac Soc. 2 (2005) 258-266
3. Stanescu D., et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 51 (1996) 267-271
4. Di Stefano A., et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am. J. Respir. Crit. Care Med. 158 (1998) 1277-1285
5. Traves S.L., et al. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2. J. Leukoc. Biol. 76 (2004) 441-450
6. Reutershan J., et al. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J. Clin. Invest. 116 (2006) 695-702
7. Smit J.J., and Lukacs N.W. A closer look at chemokines and their role in asthmatic responses. Eur. J. Pharmacol. 533 (2006) 277-288
8. Senior R.M., et al. Chemotactic activity of elastin-derived peptides. J. Clin. Invest. 66 (1980) 859-862
9. Weathington N.M., et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 12 (2006) 317-323
10. Houghton A.M., et al. Elastin fragments drive disease progression in a murine model of emphysema. J. Clin. Invest. 116 (2006) 753-759
11. Willemse B.W., et al. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur. Respir. J. 26 (2005) 835-845
12. Lapperre T.S., et al. Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax 61 (2006) 115-121
13. Mahler D.A., et al. Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study. Chest 126 (2004) 926-934